Suppr超能文献

术前 MRI 肿瘤特征与术后乳腺 X 线摄影表现:它们是否有助于完善 MRI 显示影像学完全缓解的新辅助化疗后乳腺癌患者病理完全缓解的预测?

Pre-treatment MRI tumor features and post-treatment mammographic findings: may they contribute to refining the prediction of pathologic complete response in post-neoadjuvant breast cancer patients with radiologic complete response on MRI?

机构信息

Institute of Radiology, Clinics Hospital, School of Medicine, University of São Paulo, São Paulo, Brazil.

Fleury Group, Rua Cincinato Braga, 282, Bela Vista, São Paulo, SP, 01333-010, Brazil.

出版信息

Eur Radiol. 2022 Mar;32(3):1663-1675. doi: 10.1007/s00330-021-08290-1. Epub 2021 Oct 30.

Abstract

PURPOSE

Radiologic complete response (rCR) in breast cancer patients after neoadjuvant chemotherapy (NAC) does not necessarily correlate with pathologic complete response (pCR), a marker traditionally associated with better outcomes. We sought to verify if data extracted from two important steps of the imaging workup (tumor features at pre-treatment MRI and post-treatment mammographic findings) might assist in refining the prediction of pCR in post-NAC patients showing rCR.

METHODS

A total of 115 post-NAC women with rCR on MRI (2010-2016) were retrospectively assessed. Pre-treatment MRI (lesion morphology, size, and distribution) and post-treatment mammographic findings (calcification, asymmetry, mass, architectural distortion) were assessed, as well as clinical and molecular variables. Bivariate and multivariate analyses evaluated correlation between such variables and pCR. Post-NAC mammographic findings and their correlation with ductal in situ carcinoma (DCIS) were evaluated using Pearson's correlation.

RESULTS

Tumor distribution at pre-treatment MRI was the only significant predictive imaging feature on multivariate analysis, with multicentric lesions having lower odds of pCR (p = 0.035). There was no significant association between tumor size and morphology with pCR. Mammographic residual calcifications were associated with DCIS (p = 0.009). The receptor subtype remained as a significant predictor, with HR-HER2 + and triple-negative status demonstrating higher odds of pCR on multivariate analyses.

CONCLUSIONS

Multicentric lesions on pre-NAC MRI were associated with a lower chance of pCR in post-NAC rCR patients. The receptor subtype remained a reliable predictor of pCR. Residual mammographic calcifications correlated with higher odds of malignancy, making the correlation between mammography and MRI essential for surgical planning. Key Points • The presence of a multicentric lesion on pre-NAC MRI, even though the patient reaches a radiologic complete response on MRI, is associated with a lower chance of pCR. • Molecular status of the tumor remained the only significant predictor of pathologic complete response in such patients in the present study. • Post-neoadjuvant residual calcifications found on mammography were related to higher odds of residual malignancy, making the correlation between mammography and MRI essential for surgical planning.

摘要

目的

新辅助化疗(NAC)后乳腺癌患者的放射学完全缓解(rCR)不一定与病理完全缓解(pCR)相关,pCR 是传统上与更好的预后相关的标志物。我们试图验证从影像学检查的两个重要步骤中提取的数据(治疗前 MRI 的肿瘤特征和治疗后乳腺 X 线摄影发现)是否可以帮助预测 NAC 后显示 rCR 的患者的 pCR。

方法

回顾性评估了 2010 年至 2016 年间共 115 例 NAC 后 MRI 显示 rCR 的女性患者。评估了治疗前 MRI(病变形态、大小和分布)和治疗后乳腺 X 线摄影发现(钙化、不对称、肿块、结构扭曲)以及临床和分子变量。使用二变量和多变量分析评估了这些变量与 pCR 之间的相关性。使用 Pearson 相关系数评估了 NAC 后乳腺 X 线摄影发现及其与导管原位癌(DCIS)的相关性。

结果

治疗前 MRI 的肿瘤分布是多变量分析中唯一具有显著预测意义的影像学特征,多中心病变的 pCR 可能性较低(p=0.035)。肿瘤大小和形态与 pCR 无显著相关性。乳腺 X 线摄影残余钙化与 DCIS 相关(p=0.009)。受体亚型仍然是一个显著的预测因子,HR-HER2+和三阴性状态在多变量分析中显示出更高的 pCR 可能性。

结论

NAC 前 MRI 上的多中心病变与 NAC 后 rCR 患者的 pCR 机会较低相关。肿瘤受体亚型仍然是 pCR 的可靠预测因子。乳腺 X 线摄影残余钙化与更高的恶性肿瘤几率相关,因此乳腺 X 线摄影和 MRI 之间的相关性对手术计划至关重要。

关键要点

  1. NAC 前 MRI 上存在多中心病变,即使患者在 MRI 上达到放射学完全缓解,也与 pCR 的可能性较低相关。

  2. 在本研究中,肿瘤的分子状态仍然是此类患者病理完全缓解的唯一显著预测因子。

  3. 乳腺 X 线摄影检查中发现的 NAC 后残余钙化与残余恶性肿瘤的几率较高相关,因此乳腺 X 线摄影和 MRI 之间的相关性对手术计划至关重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验